• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症患者总呼吸困难量表的编制与验证。

Development and validation of the Total Dyspnea Scale for Cancer Patients.

机构信息

Department of Nursing, Gunma Prefectural College of Health Sciences, 323-1 Kamioki-machi, Maebashi, Gunma, 371-0052, Japan.

Department of Nursing, Gunma University Graduate School of Health Sciences, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8514, Japan.

出版信息

Eur J Oncol Nurs. 2019 Aug;41:120-125. doi: 10.1016/j.ejon.2019.05.007. Epub 2019 Jun 3.

DOI:10.1016/j.ejon.2019.05.007
PMID:31358244
Abstract

PURPOSE

This study developed a comprehensive measurement tool for assessing dyspnea in cancer patients and examined its reliability and validity.

METHODS

This cross-sectional study included 239 cancer patients with awareness of cancer-related dyspnea from outpatient/inpatient wards of six general hospitals in Japan. Items for the Total Dyspnea Scale for Cancer Patients (TDSC) were developed based on qualitative research and a literature review on patients with dyspnea. Ten cancer experts confirmed the scale's content validity. Factor analysis established construct validity. Internal consistency was analyzed by Cronbach's α. Study variables were the effects of dyspnea, worry, and quality of life.

RESULTS

Factor analysis identified 2 factors (11 items): effects on "daily living activities and psychology" and on "social life." Cronbach's α of the whole scale was 0.952 (p < 0.01), confirming high reliability. The scale showed high correlation with existing measures. TDSC can comprehensively and multidimensionally evaluate cancer-related dyspnea.

CONCLUSIONS

The TDSC consists of 11 items within two factors. Cronbach's α coefficient of the scale was 0.952 in this study, and thus, an acceptable level of reliability was confirmed. In addition, reference-related validity and discriminant validity were verified and confirmed. In future clinical practice, this scale can be utilized as a useful tool for comprehensively and multidimensionally evaluating cancer-related dyspnea.

摘要

目的

本研究开发了一种全面的癌症患者呼吸困难评估工具,并对其信度和效度进行了检验。

方法

本横断面研究纳入了 239 名来自日本 6 家综合医院门诊/住院病房对癌症相关性呼吸困难有认知的癌症患者。基于对呼吸困难患者的定性研究和文献回顾,制定了癌症患者呼吸困难综合量表(TDSC)的条目。10 名癌症专家对量表的内容效度进行了确认。采用因子分析建立了结构效度。采用 Cronbach's α 分析进行内部一致性检验。研究变量为呼吸困难的影响、担忧和生活质量。

结果

因子分析确定了 2 个因子(11 个条目):对“日常生活活动和心理”的影响和对“社会生活”的影响。整个量表的 Cronbach's α 为 0.952(p<0.01),表明信度较高。该量表与现有测量工具高度相关。TDSC 可以全面、多维地评估癌症相关性呼吸困难。

结论

TDSC 由两个因子的 11 个条目组成。本研究中该量表的 Cronbach's α 系数为 0.952,因此确认了可接受的信度水平。此外,还验证并确认了参考相关的有效性和判别有效性。在未来的临床实践中,该量表可以作为一种全面、多维评估癌症相关性呼吸困难的有用工具。

相似文献

1
Development and validation of the Total Dyspnea Scale for Cancer Patients.癌症患者总呼吸困难量表的编制与验证。
Eur J Oncol Nurs. 2019 Aug;41:120-125. doi: 10.1016/j.ejon.2019.05.007. Epub 2019 Jun 3.
2
Italian Version of Cancer Dyspnea Scale: Cultural-Linguistic and Clinical Validation in Patients With Advanced Cancer Disease in Palliative Care Settings.癌症呼吸困难量表的意大利语版本:在姑息治疗环境中晚期癌症患者中的文化语言和临床验证。
J Pain Symptom Manage. 2021 Mar;61(3):571-578.e1. doi: 10.1016/j.jpainsymman.2020.10.008. Epub 2020 Oct 13.
3
Development of the Hirai Cancer Fatigue Scale: Testing its reliability and validity.平井癌症疲劳量表的开发:测试其信度和效度。
Eur J Oncol Nurs. 2015 Aug;19(4):427-32. doi: 10.1016/j.ejon.2014.12.004. Epub 2015 Feb 2.
4
Validation of "Cancer Dyspnea Scale" in Patients With Advanced Cancer in a Palliative Care Setting in India.在印度的姑息治疗环境中,对晚期癌症患者的“癌症呼吸困难量表”进行验证。
J Pain Symptom Manage. 2017 Nov;54(5):715-720.e1. doi: 10.1016/j.jpainsymman.2017.06.004. Epub 2017 Aug 8.
5
Reliability and validity of the Japanese version of the Recovery Assessment Scale (RAS) for people with chronic mental illness: scale development.慢性精神疾病患者康复评估量表(RAS)的日语版的信度和效度:量表编制。
Int J Nurs Stud. 2010 Mar;47(3):314-22. doi: 10.1016/j.ijnurstu.2009.07.006. Epub 2009 Aug 12.
6
Validity and Reliability of the Japanese Version of the Dyspnea-12 Questionnaire in Patients With Lung Cancer.肺癌患者呼吸困难 12 项问卷日本版的有效性和可靠性。
J Pain Symptom Manage. 2022 Aug;64(2):e83-e89. doi: 10.1016/j.jpainsymman.2022.04.171. Epub 2022 Apr 19.
7
Reliability and Validity of the Japanese Version of the Barthel Index Dyspnea Among Patients with Respiratory Diseases.《日本版巴氏呼吸困难指数在呼吸疾病患者中的信度和效度》
Int J Chron Obstruct Pulmon Dis. 2021 Jun 21;16:1863-1871. doi: 10.2147/COPD.S313583. eCollection 2021.
8
A meta-analysis of four randomized clinical trials to confirm the reliability and responsiveness of the Shortness of Breath with Daily Activities (SOBDA) questionnaire in chronic obstructive pulmonary disease.一项对四项随机临床试验的荟萃分析,以证实日常活动气短(SOBDA)问卷在慢性阻塞性肺疾病中的可靠性和反应性。
Health Qual Life Outcomes. 2015 Oct 31;13:177. doi: 10.1186/s12955-015-0369-3.
9
Assessment of the psychometric properties of an English version of the cancer dyspnea scale in people with advanced lung cancer.评估英文版癌症呼吸困难量表在晚期肺癌患者中的心理测量特性。
J Pain Symptom Manage. 2012 Nov;44(5):741-9. doi: 10.1016/j.jpainsymman.2011.10.027. Epub 2012 Jul 4.
10
Validation of the Clinical COPD Questionnaire in Taiwan.台湾慢性阻塞性肺疾病临床问卷的验证
COPD. 2016 Jun;13(3):360-6. doi: 10.3109/15412555.2015.1094456. Epub 2015 Dec 17.

引用本文的文献

1
Dyspnea in Oncological Patients: a Brain Teaser.肿瘤患者的呼吸困难:一道难题。
Eur Cardiol. 2023 Feb 3;18:e03. doi: 10.15420/ecr.2021.62. eCollection 2023 Feb.